Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: Analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology

S. I. Jalal, H. D. Riggs, A. Melnyk, D. Richards, A. Agarwala, M. Neubauer, R. Ansari, R. Govindan, D. Bruetman, W. Fisher, T. Breen, C. S. Johnson, M. Yu, L. Einhorn, N. Hanna

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Updated survival and outcomes for older adults with inoperable stage III non-small-cell lung cancer treated with cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel: Analysis of a phase III trial from the Hoosier Oncology Group (HOG) and US Oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences